If you liked this article you might like

These 5 Stocks Under $10 Could Explode Up Soon

ProQR Cystic Fibrosis Drug Passes First, Early Efficacy Test

5 Stocks Under $10 Set to Soar

Vertex to Test New Cystic Fibrosis Drugs, Seeking Broader, More Effective Treatments

Biotech Stock Mailbag: ProQR, Vertex Pharma, Tekmira, Agios